[ad_1]
A week ago, the Russian study was published in the prestigious scientific journal The Lancet.
The study highlights the properties of the “Sputnik V” vaccine. Therefore, it is named after the first Soviet satellite, which was launched into space in 1957.
It was already in August that Russia triumphantly announced that the vaccine had been approved in clinical trials. The Russian researchers claim that the vaccine is “safe and well received” by a couple of dozen volunteers who participated in the study.
But now 30 European researchers are questioning the data presented in the article in an open letter.
Swedish teacher: “It’s very strange”
One of those who signed the letter is Anders Björkman, Senior Lecturer in the Department of Microbiology, Cell and Tumor Biology at the Karolinska Institutet in Solna. He tells TT that he signed the letter because he cares about the real investigation.
The opinions of the researchers refer mainly to the fact that several people have developed exactly the same levels of antibodies. In different charts you can see how the levels are similar.
– It’s very strange. You could say this, if all the stats were correct, it would be extremely random. It’s so random it’s unlikely, says Anders Björkman.
Russia already has large-scale plans to manufacture the vaccine and intends, among other things, to deliver 100 million doses of “Sputnik V” to Latin American countries, Reuters reports.
See more:
Henrietta Theorell, CEO of Swedbank Robur on Sustainability Risks for Life Sciences Companies.
